Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00047580
Status:
COMPLETED
Last Update Posted:
2015-12-14
First Post:
2002-10-08
Brief Title:
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex Tizanidine Hydrochloride Tablets Taken While in the Fed State Just After a Meal and in the Fasted State Before a Meal in Patients With Moderate to Severe Spasticity
Sponsor:
Organization:
Elan Pharmaceuticals
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
120
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: